Related Experiment Video

Updated: Jun 24, 2026

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Update on the metabolic syndrome: hypertension

Kristi Reynolds1, Rachel P Wildman

  • 1Research and Evaluation, Kaiser Permanente Southern California, 100 South Los Robles, Second Floor, Pasadena, CA 91101, USA. Kristi.Reynolds@kp.org

Current Hypertension Reports
|March 13, 2009
PubMed

Insights

Metabolic syndrome increases risks for diabetes and heart disease. The best blood pressure treatment for these patients is unclear, balancing control against potential glucose intolerance.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Disorders

Background:

  • Metabolic syndrome (MetS) is a cluster of conditions increasing risks for type 2 diabetes, cardiovascular disease (CVD), and mortality.
  • Hypertension is a key component of MetS, and its presence may modify overall cardiovascular risk.
  • Current management guidelines prioritize lifestyle changes for hypertension in MetS, but pharmacologic intervention is often needed.

Purpose of the Study:

  • To review the current understanding of hypertension management in patients with metabolic syndrome.
  • To highlight the lack of consensus on optimal antihypertensive therapy in this population.
  • To identify critical areas for future research regarding blood pressure control and metabolic consequences.

Main Methods:

  • Literature review of current guidelines and research on metabolic syndrome and hypertension.
  • Analysis of the interplay between antihypertensive medications, blood pressure control, and metabolic parameters.
  • Synthesis of evidence regarding cardiovascular risk and mortality in relation to hypertension management in MetS.

Main Results:

  • Lifestyle modification is the initial recommended strategy for elevated blood pressure in MetS.
  • Pharmacologic treatment is indicated when lifestyle changes are insufficient or other risk factors are present.
  • There is no established consensus on the preferred antihypertensive drug class for MetS patients, with ongoing debate about prioritizing tight blood pressure control versus potential adverse effects on glucose metabolism.

Conclusions:

  • Hypertension management in metabolic syndrome requires careful consideration of individual risk factors and potential drug-induced metabolic changes.
  • Further research is essential to determine the optimal antihypertensive strategies that balance efficacy and safety, particularly concerning glucose tolerance.
  • Given the high prevalence of MetS and its association with diabetes, resolving treatment uncertainties is crucial for improving patient outcomes.

More Related Videos

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome06:04

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on: September 27, 2024

An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment10:31

An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment

Published on: April 20, 2018

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.